Key result
JBS3 calculator promotes more CVD risk discussion and fewer practitioner-dominated consultations than QRISK2.
Why the study?
Evidence was lacking on how NHS Health Checks are conducted, how cardiovascular disease risk is communicated to foster risk-reducing behavior, and the impact of using different risk calculators.
Does the use of the JBS3 lifetime risk calculator compared to the QRISK2 10-year risk calculator improve cardiovascular disease risk communication and patient understanding during NHS Health Checks?
RCT (n=173)
Open-label
Matched pairs randomly allocated
Yes
Does the use of the JBS3 lifetime risk calculator compared to the QRISK2 10-year risk calculator improve cardiovascular disease risk communication and patient understanding during NHS Health Checks?
Using the JBS3 lifetime risk calculator with visual representations like heart age during health checks increases CVD risk discussion and patient understanding compared to the standard QRISK2 10-year risk calculator.
Answers are grounded in this paper and cite their sources.
Supports JBS3 for improved CVD risk discussions in NHS checks; extends RCT evidence on lifetime versus 10-year calculators for communication.
BACKGROUND: The NHS Health Check is a national cardiovascular disease prevention programme. There is a lack of evidence on how health checks are conducted, how cardiovascular disease risk is communicated to foster risk-reducing intentions or behaviour, and the impact on communication of using different cardiovascular disease risk calculators. OBJECTIVES: 2 or the JBS3 lifetime risk calculator. DESIGN: This was a qualitative study with quantitative process evaluation. SETTING: Twelve general practices in the West Midlands of England, stratified on deprivation of the local area (bottom 50% vs. top 50%), and with matched pairs randomly allocated to use QRISK2 or JBS3 during health checks. PARTICIPANTS: A total of 173 patients eligible for NHS Health Check and 15 practitioners. INTERVENTIONS: The health check was delivered using either the QRISK2 10-year risk calculator (usual practice) or the JBS3 lifetime risk calculator, with heart age, event-free survival age and risk score manipulation (intervention). RESULTS: = 64 per group), and video-stimulated recall interviews were undertaken with 40 patients and 15 practitioners, with 10 in-depth case studies. The duration of the health check varied (6.8-38 minutes), but most health checks were short (60% lasting < 20 minutes), with little cardiovascular disease risk discussion (average < 2 minutes). The use of JBS3 was associated with more cardiovascular disease risk discussion and fewer practitioner-dominated consultations than the use of QRISK2. Heart age and visual representations of risk, as used in JBS3, appeared to be better understood by patients than 10-year risk (QRISK2) and, as a result, the use of JBS3 was more likely to lead to discussion of risk factors and their management. Event-free survival age was not well understood by practitioners or patients. However, a lack of effective cardiovascular disease risk discussion in both groups increased the likelihood of a maladaptive coping response (i.e. no risk-reducing behaviour change). In both groups, practitioners often missed opportunities to check patient understanding and to tailor information on cardiovascular disease risk and its management during health checks, confirming apparent practitioner verbal dominance. LIMITATIONS: The main limitations were under-recruitment in some general practices and the resulting imbalance between groups. CONCLUSIONS: Communication of cardiovascular disease risk during health checks was brief, particularly when using QRISK2. Patient understanding of and responses to cardiovascular disease risk information were limited. Practitioners need to better engage patients in discussion of and action-planning for their cardiovascular disease risk to reduce misunderstandings. The use of heart age, visual representation of risk and risk score manipulation was generally seen to be a useful way of doing this. Future work could focus on more fundamental issues of practitioner training and time allocation within health check consultations. TRIAL REGISTRATION: Current Controlled Trials ISRCTN10443908. FUNDING: ; Vol. 25, No. 50. See the NIHR Journals Library website for further project information.
No takes yet. Share an insight, caveat, or question.
Gidlow et al. (2021) conducted an RCT in Cardiovascular disease risk (n=173). JBS3 lifetime risk calculator vs. QRISK2 10-year risk calculator was evaluated on Cardiovascular disease risk discussion and consultation dynamics. The use of the JBS3 lifetime risk calculator during NHS Health Checks was associated with more cardiovascular disease risk discussion and fewer practitioner-dominated consultations compared to the QRISK2 calculator.
Synapse has enriched 10 related papers. Consider them for comparative context: